| Jessy Walia, MD | |
|
101 Sivley Rd Sw, Huntsville, AL 35801-5171 | |
| (256) 801-6036 | |
| (256) 801-6218 |
| Full Name | Jessy Walia |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 15 Years |
| Location | 101 Sivley Rd Sw, Huntsville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104225630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 39132 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntsville Hospital | Huntsville, AL | Hospital |
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hh Physicians Network | 6901132448 | 88 |
News Archive
Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an important therapy for patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age.
Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.
Patients with bipolar disorder are at increased risk for developing dementia, both pre-senile and senile, a study of a nationwide dataset in Taiwan confirms.
In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.
› Verified 8 days ago
| Entity Name | Hh Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891359683 PECOS PAC ID: 6901132448 Enrollment ID: O20190722003416 |
News Archive
Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an important therapy for patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age.
Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.
Patients with bipolar disorder are at increased risk for developing dementia, both pre-senile and senile, a study of a nationwide dataset in Taiwan confirms.
In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessy Walia, MD 101 Sivley Rd Sw, Huntsville, AL 35801 Ph: (256) 801-6036 | Jessy Walia, MD 101 Sivley Rd Sw, Huntsville, AL 35801-5171 Ph: (256) 801-6036 |
News Archive
Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an important therapy for patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age.
Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.
Patients with bipolar disorder are at increased risk for developing dementia, both pre-senile and senile, a study of a nationwide dataset in Taiwan confirms.
In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.
› Verified 8 days ago
Dr. Trevor Rudyard Lindsay, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4040 Memorial Pkwy Sw, Huntsville, AL 35802 Phone: 256-533-1970 Fax: 256-532-4112 | |
David Greer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 185 Chateau Dr Sw Ste 301, Huntsville, AL 35801 Phone: 256-265-2695 | |
Dr. Sanjay Malhotra, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 Wayne Rd Nw, Suite 6, Huntsville, AL 35806 Phone: 256-288-3333 Fax: 256-288-3334 | |
Alice A Chenault, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 608 Davis Cir Sw, Huntsville, AL 35801 Phone: 256-533-5792 Fax: 256-533-0024 | |
Douglas W Adams, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4040 Memorial Pkwy Sw, Huntsville, AL 35802 Phone: 256-533-1970 | |
Quratulain Agha, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Whitesport Dr Sw Ste 104, Huntsville, AL 35801 Phone: 256-690-5052 Fax: 833-215-8080 | |
Dr. William Houston Goodson Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4040 Memorial Pkwy Sw, Huntsville, AL 35802 Phone: 256-533-1970 Fax: 256-705-6479 |